Albemarle Corporation (ALB)
$
78.94
+0.82 (1.04%)
Key metrics
Financial statements
Free cash flow per share
-0.4665
Market cap
9.3 Billion
Price to sales ratio
1.8605
Debt to equity
0.3538
Current ratio
2.3106
Income quality
-0.8964
Average inventory
1.6 Billion
ROE
-0.0919
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Albemarle Corporation, founded in 1887 and headquartered in Charlotte, North Carolina, is a global leader in the development, manufacturing, and marketing of engineered specialty chemicals. The company operates through three primary segments: Lithium, Bromine, and Catalysts. The Lithium segment specializes in a range of lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and various lithium specialties, alongside reagents such as butyllithium and lithium aluminum hydride. These products are essential for lithium batteries used in consumer electronics and electric vehicles, as well as in high-performance greases and thermoplastic elastomers for automotive applications. Additionally, Albemarle provides cesium products for the chemical and pharmaceutical industries, along with zirconium, barium, and titanium products for pyrotechnical uses, including airbag initiators. The company also offers technical services related to reactive lithium products and recycling services for lithium-containing by-products. In terms of financial performance, the operating expenses amount to $1,839,084,000.00 encompassing various operational costs incurred. The net income ratio is -0.22 reflecting the company's profitability margin, while the net total of other income and expenses is $12,720,000.00 indicating non-core financial activities. Furthermore, the company earned an interest income of $0.00 showcasing its financial investments, and incurred an income tax expense of $87,085,000.00 which indicates its tax obligations. The Bromine segment presents a rich portfolio of bromine and bromine-based fire safety solutions, alongside specialty chemicals used in diverse applications such as chemical synthesis, water purification, and the agricultural sector, while the Catalysts segment offers a variety of catalysts essential for hydroprocessing, isomerization, and refining processes. In the current market, the stock is reasonably priced at $71.87 appealing to a broad range of investors. It demonstrates strong liquidity with a high average trading volume of 4,414,956.00. With a mid-range market capitalization of $9,289,896,020.00 the company has proven itself as a steady performer. It is a key player in the Chemicals - Specialty industry, contributing significantly to the overall market landscape, while belonging to the Basic Materials sector, which drives innovation and growth. This combination of financial stability and robust market presence positions Albemarle Corporation as a compelling choice for investors seeking reliable performance in the specialty chemicals landscape.
Is Albemarle Corporation (ALB) a good investment?
Investing in Albemarle Corporation (ALB) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as C, with a Bullish outlook. Always conduct your own research before investing.
What is Albemarle Corporation (ALB)'s stock forecast?
Analysts predict Albemarle Corporation stock to fluctuate between $49.43 (low) and $113.91 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is Albemarle Corporation's market capitalization?
As of 2025-08-22, Albemarle Corporation's market cap is $9,289,896,020, based on 117,683,000 outstanding shares.
How does Albemarle Corporation compare to competitors like The Sherwin-Williams Company?
Compared to The Sherwin-Williams Company, Albemarle Corporation has a Lower Market-Cap, indicating a difference in performance.
Does Albemarle Corporation pay dividends?
Albemarle Corporation pays dividends. The current dividend yield is 1.99%, with a payout of $0.41 per share.
How can I buy Albemarle Corporation (ALB) stock?
To buy Albemarle Corporation (ALB) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for ALB. Place an order (Market, Limit, etc.).
What is the best time to invest in Albemarle Corporation?
The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.
Has Albemarle Corporation stock ever split?
Albemarle Corporation's last stock split was 2:1 on 2007-03-02.
How did Albemarle Corporation perform in the last earnings report?
Revenue: $5,377,526,000 | EPS: -$11.20 | Growth: -183.52%.
Where can I find Albemarle Corporation's investor relations reports?
Visit https://www.albemarle.com/investor-relations for detailed financial reports.
Where can I find historical stock prices for Albemarle Corporation?
You can explore historical data from here
What is the all-time high and low for Albemarle Corporation stock?
All-time high: $334.55 (2022-11-11) | All-time low: $49.43 (2025-04-08).
What are the key trends affecting Albemarle Corporation stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
businesswire.com
HOUSTON--(BUSINESS WIRE)-- #SaFeGuard--Ketjen Corporation, a leader in catalyst and specialty chemicals manufacturing has launched SaFeGuard™, a new catalyst technology designed to address iron (Fe) poisoning in FCC units. In a recent 30-day full commercial trial, SaFeGuard™ demonstrated a 77% improvement in accessibility with a 50% inventory replacement enabling an increase in unit activity, improved bottoms cracking, and ability to process heavy iron-rich feedstocks. Further testing and predictive modelin.
investorplace.com
“The only thing I want to know,” investment guru Charlie Munger once quipped, “is where I'm going to die so I never go there.” Warren Buffett's right-hand man was onto something.
reuters.com
Albemarle , the world's largest producer of lithium for rechargeable batteries, said on Monday that Chief Operating Officer Netha Johnson will leave the company.
prnewswire.com
Aligns the company's functional model for greater agility and efficiency and is designed to accelerate market-led growth and operational excellence CHARLOTTE, N.C. , Aug. 11, 2025 /PRNewswire/ -- Albemarle Corporation (NYSE: ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced changes to its organizational structure to further align the company for agility and efficiency.
proactiveinvestors.com
Albemarle Corporation (NYSE:ALB, ETR:AMC) reported an unexpected second-quarter profit on Thursday, as steady demand for lithium used in electric vehicles and energy storage helped offset a volatile pricing environment. The US-based lithium producer posted adjusted earnings of $0.11 per share, beating analysts' expectations of a $0.78 loss.
seekingalpha.com
Albemarle Corporation (NYSE:ALB ) Q2 2025 Earnings Conference Call July 31, 2025 8:00 AM ET Company Participants Jerry Kent Masters - Chairman, President & CEO Meredith H. Bandy - Vice President of Investor Relations & Sustainability Neal R.
zacks.com
ALB tops Q2 earnings estimates despite a 7% revenue dip, as lower lithium prices weigh on results.
zacks.com
Albemarle (ALB) came out with quarterly earnings of $0.11 per share, beating the Zacks Consensus Estimate of a loss of $0.83 per share. This compares to earnings of $0.04 per share a year ago.
prnewswire.com
CHARLOTTE, N.C. , July 30, 2025 /PRNewswire/ -- Albemarle Corporation (NYSE: ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, announced today that Ander Krupa has been promoted to executive vice president, general counsel, corporate secretary and chief compliance officer.
marketbeat.com
With new all-time high valuations for the S&P 500 and Nasdaq-100 in full swing, more and more investors are growing wary of buying new names for their portfolios, and for good reason. Buying near the top of the valuation cycle is always a scary thing.
See all news
